Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

PF-5006739

Inquiry
Cat. No.: OB0425LY-087
Synonyms: 1293395-67-1; PF 5006739; 2-Pyrimidinamine, 4-[4-(4-fluorophenyl)-1-[1-(3-isoxazolylmethyl)-4-piperidinyl]-1H-imidazol-5-yl]-; 4-[4-(4-Fluorophenyl)-1-[1-(3-isoxazolylmethyl)-4-piperidinyl]-1H-imidazol-5-yl]-2-pyrimidinamine
Size: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg; 500 mg
CAS No.: 1293395-67-1
Compound CID: 51353555
PF-5006739

Specification

Description: PF-5006739 is a potent and selective CK1δ/ε inhibitor.
Formula Weight: 419.45
Applications: PF-5006739 can be used to improve glucose tolerance in diet-induced obesity (DIO) and genetic obesity (ob/ob) mouse models.
Storage: Storage at 4°C.
Formula: C22H22FN7O
Appearance: Solid
Purity: 99.56% determined by HPLC.
Solubility: DMSO
Pathway: Cell cycle/DNA damage; Stem cell/Wnt
Identity: Confirmed by NMR and MS.
Target: Casein kinase

Library Information

Solubility: DMSO
Inquiry

Copyright © Protheragen. All rights reserves.